COL4A1 and breast cancer: We found that low COL4A1 expression was associated with a poor prognosis for overall survival (OS) for breast cancer patients who received neoadjuvant chemotherapy (P=0.057, Figure 5(b)) (https://kmplot.com/analysis/index.php?p=service&cancer=breast).